Literature DB >> 20562108

Allosteric block of KCa2 channels by apamin.

Cédric Lamy1, Samuel J Goodchild, Kate L Weatherall, David E Jane, Jean-François Liégeois, Vincent Seutin, Neil V Marrion.   

Abstract

Activation of small conductance calcium-activated potassium (K(Ca)2) channels can regulate neuronal firing and synaptic plasticity. They are characterized by their high sensitivity to the bee venom toxin apamin, but the mechanism of block is not understood. For example, apamin binds to both K(Ca)2.2 and K(Ca)2.3 with the same high affinity (K(D) approximately 5 pM for both subtypes) but requires significantly higher concentrations to block functional current (IC(50) values of approximately 100 pM and approximately 5 nM, respectively). This suggests that steps beyond binding are needed for channel block to occur. We have combined patch clamp and binding experiments on cell lines with molecular modeling and mutagenesis to gain more insight into the mechanism of action of the toxin. An outer pore histidine residue common to both subtypes was found to be critical for both binding and block by the toxin but not for block by tetraethylammonium (TEA) ions. These data indicated that apamin blocks K(Ca)2 channels by binding to a site distinct from that used by TEA, supported by a finding that the onset of block by apamin was not affected by the presence of TEA. Structural modeling of ligand-channel interaction indicated that TEA binds deep within the channel pore, which contrasted with apamin being modeled to interact with the channel outer pore by utilizing the outer pore histidine residue. This multidisciplinary approach suggested that apamin does not behave as a classical pore blocker but blocks using an allosteric mechanism that is consistent with observed differences between binding affinity and potency of block.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562108      PMCID: PMC2930706          DOI: 10.1074/jbc.M110.110072

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels.

Authors:  M Grunnet; B S Jensen; S P Olesen; D A Klaerke
Journal:  Pflugers Arch       Date:  2001-01       Impact factor: 3.657

Review 2.  Ca(2+)-activated K+ channels: molecular determinants and function of the SK family.

Authors:  Martin Stocker
Journal:  Nat Rev Neurosci       Date:  2004-10       Impact factor: 34.870

3.  Identification of a pharmacophore of SKCa channel blockers.

Authors:  Sebastien Dilly; Amaury Graulich; Amaury Farce; Vincent Seutin; Jean-Francois Liegeois; Philippe Chavatte
Journal:  J Enzyme Inhib Med Chem       Date:  2005-12       Impact factor: 5.051

Review 4.  Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry.

Authors:  J-F Liégeois; F Mercier; A Graulich; F Graulich-Lorge; J Scuvée-Moreau; V Seutin
Journal:  Curr Med Chem       Date:  2003-04       Impact factor: 4.530

5.  Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells.

Authors:  T J Dale; J E Cryan; M X Chen; D J Trezise
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-09-06       Impact factor: 3.000

6.  Design and characterization of a highly selective peptide inhibitor of the small conductance calcium-activated K+ channel, SkCa2.

Authors:  V G Shakkottai; I Regaya; H Wulff; Z Fajloun; H Tomita; M Fathallah; M D Cahalan; J J Gargus; J M Sabatier; K G Chandy
Journal:  J Biol Chem       Date:  2001-08-29       Impact factor: 5.157

7.  Characterisation of [(125)I]-apamin binding sites in rat brain membranes with HE293 cells transfected with SK channel subtypes.

Authors:  K Finlayson; J McLuckie; J Hern; I Aramori; H J Olverman; J S Kelly
Journal:  Neuropharmacology       Date:  2001-09       Impact factor: 5.250

8.  The SK3 subunit of small conductance Ca2+-activated K+ channels interacts with both SK1 and SK2 subunits in a heterologous expression system.

Authors:  Alan S Monaghan; David C H Benton; Parmvir K Bahia; Ramine Hosseini; Yousaf A Shah; Dennis G Haylett; Guy W J Moss
Journal:  J Biol Chem       Date:  2003-10-14       Impact factor: 5.157

9.  Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.

Authors:  Heike Jäger; Stephan Grissmer
Journal:  Toxicon       Date:  2004-06-15       Impact factor: 3.033

10.  Methyl-laudanosine: a new pharmacological tool to investigate the function of small-conductance Ca(2+)-activated K(+) channels.

Authors:  Jacqueline Scuvee-Moreau; Jean-François Liegeois; Laurent Massotte; Vincent Seutin
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

View more
  34 in total

1.  Crucial role of a shared extracellular loop in apamin sensitivity and maintenance of pore shape of small-conductance calcium-activated potassium (SK) channels.

Authors:  Kate L Weatherall; Vincent Seutin; Jean-François Liégeois; Neil V Marrion
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

Review 2.  Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).

Authors:  Palle Christophersen; Heike Wulff
Journal:  Channels (Austin)       Date:  2015-07-28       Impact factor: 2.581

Review 3.  The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.

Authors:  Jenny Lam; Nichole Coleman; April Lourdes A Garing; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2013-07-25       Impact factor: 6.902

4.  Hippocampal mGluR1-dependent long-term potentiation requires NAADP-mediated acidic store Ca2+ signaling.

Authors:  William J Foster; Henry B C Taylor; Zahid Padamsey; Alexander F Jeans; Antony Galione; Nigel J Emptage
Journal:  Sci Signal       Date:  2018-11-27       Impact factor: 8.192

5.  A Comparison of the Ability of Leu8- and Pro8-Oxytocin to Regulate Intracellular Ca2+ and Ca2+-Activated K+ Channels at Human and Marmoset Oxytocin Receptors.

Authors:  Marsha L Pierce; Suneet Mehrotra; Aaryn C Mustoe; Jeffrey A French; Thomas F Murray
Journal:  Mol Pharmacol       Date:  2019-02-09       Impact factor: 4.436

6.  Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels.

Authors:  David Paul Jenkins; Dorte Strøbæk; Charlotte Hougaard; Marianne L Jensen; Rene Hummel; Ulrik S Sørensen; Palle Christophersen; Heike Wulff
Journal:  Mol Pharmacol       Date:  2011-03-01       Impact factor: 4.436

7.  SK2 and SK3 expression differentially affect firing frequency and precision in dopamine neurons.

Authors:  J Deignan; R Luján; C Bond; A Riegel; M Watanabe; J T Williams; J Maylie; J P Adelman
Journal:  Neuroscience       Date:  2012-04-30       Impact factor: 3.590

8.  Proarrhythmic effect of blocking the small conductance calcium activated potassium channel in isolated canine left atrium.

Authors:  Chia-Hsiang Hsueh; Po-Cheng Chang; Yu-Cheng Hsieh; Thomas Reher; Peng-Sheng Chen; Shien-Fong Lin
Journal:  Heart Rhythm       Date:  2013-01-30       Impact factor: 6.343

Review 9.  Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets.

Authors:  Heike Wulff; Ralf Köhler
Journal:  J Cardiovasc Pharmacol       Date:  2013-02       Impact factor: 3.105

10.  Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor.

Authors:  Marsha L Pierce; Jeffrey A French; Thomas F Murray
Journal:  Biomed Pharmacother       Date:  2020-03-04       Impact factor: 6.529

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.